Femoral Neuropathy Associated with Prophylactic Anticoagulation in a Patient with Severe COVID-19: A Case Report
Keywords:Anticoagulants/adverse effects, COVID-19/complications, Femoral Neuropathy/chemically induced
Allegra A, Innao V, Allegra AG, Musolino C. Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies. Ann Hematol. 2020;99:1953-65. DOI: https://doi.org/10.1007/s00277-020-04182-4
Preston DC, Shapiro BE. Femoral neuropathy. In: Electromyography and neuromuscular disorders. Philadelphia: Elsevier; 2021. p. 459-67.
Tosun A, İnal E, Keleş I, Tulmaç M, Tosun Ö, Aydın G, et al. Conservative treatment of femoral neuropathy following retroperitoneal hemorrhage: a case report and review of literature. Blood Coagul Fibrinolysis. 2014;25:769-72. DOI: https://doi.org/10.1097/MBC.0000000000000110
How to Cite
Copyright (c) 2023 Acta Médica Portuguesa
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.